News

Cartesian: Autoimmune Cell Therapy Excites, But Reality Bites
Cartesian's mRNA-based cell therapy offers a novel, outpatient approach for autoimmune diseases. Promising results, but Phase ...
CAR T-Cell Therapy Market to Surge at 40.2% CAGR Over the Next Five Years
Market Trends, Business Strategies, Competitive Intelligence, Clinical Trials, and Patent Trends Driving Growth from 2024 to 2029"Boston, July 10, 2025 (GLOBE NEWSWIRE) -- According to the latest ...